vaxil-bio.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php
Sitemap: https://vaxil-bio.com/wp-sitemap.xml
Meta Tags
Title Vaxil Bio – Creating the ideal
Description Vaxil Locations Contact Us Subscribe About Vaxil TEAM INTELLECTUAL PROPERTY News and Updates In the Media VAXIL Creating the ideal immunotherapy Inducing
Keywords N/A
Server Information
WebSite vaxil-bio faviconvaxil-bio.com
Host IP 107.180.40.41
Location United States
Related Websites
Site Rank
More to Explore
vaxil-bio.com Valuation
US$3,099,776
Last updated: 2022-06-29 01:22:34

vaxil-bio.com has Semrush global rank of 3,414,539. vaxil-bio.com has an estimated worth of US$ 3,099,776, based on its estimated Ads revenue. vaxil-bio.com receives approximately 357,667 unique visitors each day. Its web server is located in United States, with IP address 107.180.40.41. According to SiteAdvisor, vaxil-bio.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$3,099,776
Daily Ads Revenue US$2,862
Monthly Ads Revenue US$85,840
Yearly Ads Revenue US$1,030,080
Daily Unique Visitors 23,845
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
vaxil-bio.com. A 10799 IP: 107.180.40.41
vaxil-bio.com. NS 3600 NS Record: ns24.domaincontrol.com.
vaxil-bio.com. NS 3600 NS Record: ns23.domaincontrol.com.
vaxil-bio.com. MX 3600 MX Record: 5 alt1.aspmx.l.google.com.
vaxil-bio.com. MX 3600 MX Record: 5 alt2.aspmx.l.google.com.
vaxil-bio.com. MX 3600 MX Record: 10 alt3.aspmx.l.google.com.
vaxil-bio.com. MX 3600 MX Record: 10 alt4.aspmx.l.google.com.
vaxil-bio.com. MX 3600 MX Record: 1 aspmx.l.google.com.
vaxil-bio.com. TXT 3600 TXT Record: google-site-verification=fTilWqx_I3O3C4C5tBv_VHB2TtADr-JYTnjDQugZ1RI
HtmlToTextCheckTime:2022-06-29 01:22:34
Vaxil Locations Contact Us Subscribe About Vaxil TEAM INTELLECTUAL PROPERTY News and Updates In the Media VAXIL Creating the ideal immunotherapy Inducing a Broad Response Learn More universally Applicable Learn More Overcoming Cancer Resistance Learn More Harnessing Potent Immune Response Learn More Tumor Specific Learn More Expression on Cancer Stem Cells Learn More neo-antigen acting Learn More First-ever SP-Specific Antibody Platform Learn More Vaxil’s Lead Products and Orphan Drug Status Vaxil believes its immunotherapy platform allows it to target high profile cancer antigens in a uniquely superior manner, all designed to possess the novel advantages described above. Vaxil’s first test of its VaxHit™ platform is its Immucin™ ; lead immunotherapy product. After completion of a successful Phase-I/II in 15 multiple myeloma cancer patients, Vaxil’s Immucin™ was granted Orphan Drug Status by the FDA and EMA for that indication. Vaxil’s Lead Immunotherapy Immucin™ Obtains Orphan Drug
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Tue, 26 Oct 2021 12:51:45 GMT
Server: Apache
X-Powered-By: PHP/5.6.40
X-Redirect-By: WordPress
Upgrade: h2,h2c
Connection: Upgrade
Location: https://vaxil-bio.com/
Content-Type: text/html; charset=UTF-8

HTTP/2 200 
x-powered-by: PHP/5.6.40
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
content-type: text/html; charset=UTF-8
date: Tue, 26 Oct 2021 12:51:47 GMT
server: Apache
vaxil-bio.com Whois Information
Domain Name: VAXIL-BIO.COM
Registry Domain ID: 2504172090_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-03-16T19:03:45Z
Creation Date: 2020-03-16T19:03:45Z
Registry Expiry Date: 2022-03-16T19:03:45Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS23.DOMAINCONTROL.COM
Name Server: NS24.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-14T13:04:04Z <<<